Compounds that selectively negatively modulate NMDA receptors containing an NR1/NR2B subunit, pharmaceutical compositions comprising the compounds, and methods of treating a disease using the compounds are disclosed.
本发明公开了选择性负向调节含有NR1/NR2B亚基的N
MDA受体的化合物,包括该化合物的制药组合物,以及使用该化合物治疗疾病的方法。